Myriad Genetics Inc (MYGN)
8.41
-0.39
(-4.43%)
USD |
NASDAQ |
Apr 03, 16:00
Myriad Genetics Profit Margin (Quarterly): -20.18% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ResMed Inc | 26.88% |
| Biomarin Pharmaceutical Inc | 16.72% |
| Moderna Inc | -117.2% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.11% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.13% |
| Return on Assets | -11.68% |
| Return on Invested Capital | -16.27% |
| Gross Profit Margin (Quarterly) | 71.65% |
| Operating Margin (Quarterly) | -8.21% |
| Return on Net Operating Assets | -12.69% |